Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott; Penumbra; Innova; Recor Medical; Trireme; Boston Scientific Corporation; Philips
- Consultant Fee/Honoraria/Speaker's Bureau - Inquis; Abbott; Asahi; Penumbra; Angiodynamics; Philips; Boston Scientific Corporation; Shockwave Medical; Cordis Corporation, a Johnson & Johnson company
- Equity/Stock(s)/Options - Protexa; Akura; Innova; Evident